ANXA1sp Protects against Sepsis-Induced Myocardial Injury by Inhibiting Ferroptosis-Induced Cardiomyocyte Death via SIRT3-Mediated p53 Deacetylation

Figure 1

ANXA1sp inhibits LPS-induced H9C2 cell damage. H9C2 cells were assigned to control, LPS, and LPS+ANXA1sp groups. (a) CCK-8 for H9C2 cell viability. (b) LDH level in H9C2 cell supernatant. (c–e) ELISA for TNF-α, IL-1β, and IL-6 levels in H9C2 cell supernatant. The experiments were repeated three times (). Data were presented as . All statistical analyses were performed using Student’s -test or one-way ANOVA. ; ; .

(a)

(b)

(c)

(d)

(e)